Author:
Lee Thomas W.,Fedorak Richard N.
Reference77 articles.
1. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key;Dharmani;Curr Mol Pharmacol,2008
2. General principles and pharmacology of biologics in inflammatory bowel disease;Kozuch;Gastroenterol Clin North Am,2006
3. Transmembrane TNF-{alpha}: structure, function and interaction with anti-TNF agents;Horiuchi;Rheumatology (Oxford),2010
4. Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor;Kaymakcalan;Clin Immunol,2009
5. Optimizing the use of tumour necrosis factor inhibitors in Crohn’s disease: a practical approach;Etchevers;Drugs,2010
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献